VIATRIS US HOLDINGS 4 LLC – Trademark Portfolio
Entity Type: 16
VIATRIS US HOLDINGS 4 LLC holds 5 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 5 (Pharmaceuticals) — 4 filings in this category. The portfolio also extends into Class 44 (Medical Services) across 3 Nice Classification classes. Currently, 2 trademarks are registered. Notable registered marks include CADUET. The owner is based in CANONSBURG, PA.
1000 MYLAN BOULEVARD
CANONSBURG, PA 15317
Showing of trademarks Trademarks
Trademark Classifications
VIATRIS US HOLDINGS 4 LLC's trademark portfolio spans 3 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes
Medical services; veterinary services; hygienic and beauty care for human beings or animals
Paper and cardboard; printed matter; bookbinding material; photographs; stationery
Frequently Asked Questions
How many trademarks does VIATRIS US HOLDINGS 4 LLC have?
VIATRIS US HOLDINGS 4 LLC has 5 U.S. trademarks filed with the USPTO. Of these, 2 registered, 1 abandoned, 2 cancelled.
What trademark classes does VIATRIS US HOLDINGS 4 LLC file in?
VIATRIS US HOLDINGS 4 LLC files trademarks across 3 Nice Classification classes. The most active classes are Class 5 (Pharmaceuticals), Class 44 (Medical Services), Class 16 (Paper Goods). Class 5 covers pharmaceutical and veterinary preparations; sanitary preparations for medical purposes.
What are VIATRIS US HOLDINGS 4 LLC's most well-known trademarks?
VIATRIS US HOLDINGS 4 LLC's registered trademark portfolio includes well-known marks such as CADUET. These are among 2 currently registered trademarks in the portfolio.
What is VIATRIS US HOLDINGS 4 LLC's trademark registration success rate?
VIATRIS US HOLDINGS 4 LLC has a 40% trademark registration rate, with 2 out of 5 resolved applications resulting in successful registration. Currently, 0 applications are pending review.